0001808805-23-000059.txt : 20230616 0001808805-23-000059.hdr.sgml : 20230616 20230616195204 ACCESSION NUMBER: 0001808805-23-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Epperly Melissa B, CENTRAL INDEX KEY: 0001807359 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 231022950 MAIL ADDRESS: STREET 1: C/O ZENTALIS PHARMACEUTICALS, INC. STREET 2: 530 SEVENTH AVENUE, SUITE 2201 CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 981541723 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 wf-form4_168695951498248.xml FORM 4 X0407 4 2023-06-15 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001807359 Epperly Melissa B, C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVE. E. SEATTLE WA 98102 1 0 0 0 0 Stock Option (Right to Buy) 3.97 2023-06-15 4 A 0 45000 0 A 2033-06-15 Common Stock 45000.0 45000 D Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). /s/ Anna Mowry, as Attorney-in-Fact 2023-06-16